| Macrophage-induced blood vessels guide Schwann cell-mediated regeneration of peripheral nerves AL Cattin, JJ Burden, L Van Emmenis, FE Mackenzie, JJA Hoving, ... Cell 162 (5), 1127-1139, 2015 | 704 | 2015 |
| A GRFa2/Prop1/stem (GPS) cell niche in the pituitary M Garcia-Lavandeira, V Quereda, I Flores, C Saez, E Diaz-Rodriguez, ... PLoS One 4 (3), e4815, 2009 | 185 | 2009 |
| Therapeutic targeting of CDK12/CDK13 in triple-negative breast cancer V Quereda, S Bayle, F Vena, SM Frydman, A Monastyrskyi, WR Roush, ... Cancer cell 36 (5), 545-558. e7, 2019 | 172 | 2019 |
| Cell cycle control of pituitary development and disease. V Quereda, M Malumbres Journal of Molecular Endocrinology 42 (2), 75-86, 2008 | 112 | 2008 |
| Therapeutic targeting of casein kinase 1δ in breast cancer LH Rosenberg, M Lafitte, V Quereda, W Grant, W Chen, M Bibian, ... Science translational medicine 7 (318), 318ra202-318ra202, 2015 | 72 | 2015 |
| Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression V Quereda, J Martinalbo, P Dubus, A Carnero, M Malumbres Oncogene 26 (55), 7665-7674, 2007 | 51 | 2007 |
| Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer A Monastyrskyi, N Nilchan, V Quereda, Y Noguchi, C Ruiz, W Grant, ... Bioorganic & medicinal chemistry 26 (3), 590-602, 2018 | 29 | 2018 |
| Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis E Rodríguez-Díez, V Quereda, F Bellutti, M Prchal-Murphy, D Partida, ... Blood, The Journal of the American Society of Hematology 124 (15), 2380-2390, 2014 | 28 | 2014 |
| An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress V Quereda, E Porlan, M Canãmero, P Dubus, M Malumbres Cell Death & Differentiation 23 (3), 430-441, 2016 | 27 | 2016 |
| A cytotoxic three-dimensional-spheroid, high-throughput assay using patient-derived glioma stem cells V Quereda, S Hou, F Madoux, L Scampavia, TP Spicer, D Duckett SLAS DISCOVERY: Advancing Life Sciences R&D 23 (8), 842-849, 2018 | 26 | 2018 |
| HDAC3 regulates the transition to the homeostatic myelinating Schwann cell state LH Rosenberg, AL Cattin, X Fontana, E Harford-Wright, JJ Burden, ... Cell Reports 25 (10), 2755-2765. e5, 2018 | 22 | 2018 |
| Identification of an EGFRvIII-JNK2-HGF/c-Met–Signaling Axis Required for Intercellular Crosstalk and Glioblastoma Multiforme Cell Invasion VC Saunders, M Lafitte, I Adrados, V Quereda, D Feurstein, YY Ling, ... Molecular Pharmacology 88 (6), 962-969, 2015 | 14 | 2015 |
| βarrestin-1 regulates DNA repair by acting as an E3-ubiquitin ligase adaptor for 53BP1 A Nieto, MR Hara, V Quereda, W Grant, V Saunders, K Xiao, ... Cell Death & Differentiation 27 (4), 1200-1213, 2020 | 13 | 2020 |
| Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interaction Z Wang, M Zhang, V Quereda, SM Frydman, Q Ming, VC Luca, ... Journal of medicinal chemistry 64 (16), 12109-12131, 2021 | 9 | 2021 |
| Targeting casein kinase 1 delta sensitizes pancreatic and bladder cancer cells to gemcitabine treatment by upregulating deoxycytidine kinase F Vena, S Bayle, A Nieto, V Quereda, M Aceti, SM Frydman, SS Sansil, ... Molecular cancer therapeutics 19 (8), 1623-1635, 2020 | 8 | 2020 |
| Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors A Monastyrskyi, S Bayle, V Quereda, W Grant, M Cameron, D Duckett, ... Bioorganic & medicinal chemistry letters 28 (3), 400-404, 2018 | 8 | 2018 |
| Therapeutic targeting of casein kinase 1d in breast cancer LH Rosenberg, M Lafitte, V Quereda, W Grant, W Chen, M Bibian, ... Sci. Transl. Med 7, 1-24, 0 | 1 | |
| Targeting cdk12/13 re-sensitizes trastuzumab resistant her2+ breast cancers F Vena, M Aceti, S Bayle, V Quereda, A Monastyrskyi, W Roush, ... Cancer Research 79 (13_Supplement), 3051-3051, 2019 | | 2019 |
| Abstract P2-06-08: Withdrawn F Vena, S Bayle, V Quereda, A Monastyrskyi, D Duckett Cancer Research 79 (4_Supplement), P2-06-08-P2-06-08, 2019 | | 2019 |
| Abstract P1-06-03: A selective Cdk12/13 non-covalent inhibitor with potent anti-breast cancer activity V Quereda, S Bayle, V Francesca, M Andrii, R William Cancer Research 79 (4_Supplement), P1-06-03-P1-06-03, 2019 | | 2019 |
